Alcohol dependence

United States Alcohol Dependence Market Analysis and Competitive Landscape Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, October 26, 2022

The "US Alcohol Dependence Market and Competitive Landscape - 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "US Alcohol Dependence Market and Competitive Landscape - 2022" report has been added to ResearchAndMarkets.com's offering.
  • The report provides comprehensive insights into Alcohol Dependence pipeline products, Alcohol Dependence epidemiology, Alcohol Dependence market valuations and forecast, Alcohol Dependence drugs sales and competitive landscape in the US.
  • Alcohol Dependence pipeline: Find out the products in clinical trials for the treatment of Alcohol Dependence by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
    Alcohol Dependence drugs: Identify key products marketed and prescribed for Alcohol Dependence in the US, including trade name, molecule name, and company
    Alcohol Dependence market valuations: Find out the market size for Alcohol Dependence drugs in 2021 in the US.
  • Find out how the market advanced from 2019 and forecast to 2027
    Alcohol Dependence drugs market share: Find out the market shares for key Alcohol Dependence drugs in the US
    Evaluate commercial market opportunity assessment, positioning, and segmentation for Alcohol Dependence products

Europe Alcohol Dependence Market Analysis and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Drug Sales, Forecasts, and Market Shares 2018-2026 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 29, 2022

The "Europe Alcohol Dependence Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Alcohol Dependence Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • The research provides comprehensive insights into Alcohol Dependence pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Alcohol Dependence treatment options, Alcohol Dependence late-stage clinical trials pipeline, Alcohol Dependence prevalence by countries, Alcohol Dependence market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Alcohol Dependence pipeline: Find out drugs in clinical trials for the treatment of Alcohol Dependence by development phase 3, phase 2, by pharmacological class and company
    Alcohol Dependence drugs: Identify key drugs marketed and prescribed for Alcohol Dependence in the US, including trade name, molecule name, and company
    Alcohol Dependence market valuations: Find out the market size for Alcohol Dependence drugs in 2020 by countries.

Substance Abuse Treatment Global Market Forecast to 2027: Growing Cases of Tobacco Addiction Globally - ResearchAndMarkets.com

Retrieved on: 
Thursday, June 9, 2022

The "Substance Abuse Treatment Market Research Report by Treatment, Product, Distribution Channel, Region - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Substance Abuse Treatment Market Research Report by Treatment, Product, Distribution Channel, Region - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The report categorizes the Substance Abuse Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Treatment, the market was studied across Alcohol Addiction Treatment and Nicotine Addiction Treatment.
  • Based on Product, the market was studied across Alcohol Dependence, Opioid Addiction, and Tobacco Addiction.
  • The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market.

Alcohol Dependence: 2021 Industry Overview and Opportunity Assessment by Drugs & Countries - ResearchAndMarkets.com

Retrieved on: 
Friday, October 1, 2021

The "Global Alcohol Dependence Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Alcohol Dependence Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive insights into Alcohol Dependence pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • The report covers the following: Alcohol Dependence treatment options, Alcohol Dependence late-stage clinical trials pipeline, Alcohol Dependence prevalence by countries, Alcohol Dependence market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Alcohol Dependence pipeline: Find out drugs in clinical trials for the treatment of Alcohol Dependence by development phase 3, phase 2, by pharmacological class and company
    Alcohol Dependence drugs: Identify key drugs marketed and prescribed for Alcohol Dependence in the US, including trade name, molecule name, and company
    Alcohol Dependence market valuations: Find out the market size for Alcohol Dependence drugs in 2020 by countries.

Kinnov-Therapeutics Completes Recruitment of KT-110 Phase 2 Clinical Trial in Alcohol Dependence Disorders

Retrieved on: 
Monday, August 30, 2021

The founders of KINNOV have shown that the combination of cyproheptadine and prazosin has therapeutic effects in experimental models of addiction.

Key Points: 
  • The founders of KINNOV have shown that the combination of cyproheptadine and prazosin has therapeutic effects in experimental models of addiction.
  • KT-110 is composed of these two molecules and exerts its therapeutic effect on addiction, rather than through a substitution effect.
  • In animal models, KT-110 has already shown greater efficacy than standard treatments (Nalmefene, Naltrexone and Baclofene) on alcohol consumption.
  • At that time, Kinnov-Therapeutics will seek a partner to launch a large-scale Phase 3 trial allowing a market launch between 2025 and 2026.

Alkermes Presented New Data Analysis on Healthcare Resource Use Among Veterans With Alcohol Dependence

Retrieved on: 
Wednesday, June 30, 2021

The company presented results from a retrospective, observational study using data from the Veterans Health Administration (VHA) database, which includes healthcare encounters, treatments and laboratory tests at VHA facilities.

Key Points: 
  • The company presented results from a retrospective, observational study using data from the Veterans Health Administration (VHA) database, which includes healthcare encounters, treatments and laboratory tests at VHA facilities.
  • Details of the poster presentation at RSA are as follows:
    Poster #240: Treatment Patterns and Healthcare Resource Use Among Patients with Alcohol Dependence who Initiated Extended-Release Naltrexone: An Analysis of Veterans Affairs Data, was presented Sunday, June 20.
  • That study was one of the first studies to provide insights into the patient journey among veterans from alcohol dependence diagnosis to VIVITROL initiation and beyond.
  • Treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL.

Alkermes Presented New Data Analysis on Healthcare Resource Use Among Veterans With Alcohol Dependence

Retrieved on: 
Wednesday, June 30, 2021

The company presented results from a retrospective, observational study using data from the Veterans Health Administration (VHA) database, which includes healthcare encounters, treatments and laboratory tests at VHA facilities.

Key Points: 
  • The company presented results from a retrospective, observational study using data from the Veterans Health Administration (VHA) database, which includes healthcare encounters, treatments and laboratory tests at VHA facilities.
  • Details of the poster presentation at RSA are as follows:
    Poster #240: Treatment Patterns and Healthcare Resource Use Among Patients with Alcohol Dependence who Initiated Extended-Release Naltrexone: An Analysis of Veterans Affairs Data, was presented Sunday, June 20.
  • That study was one of the first studies to provide insights into the patient journey among veterans from alcohol dependence diagnosis to VIVITROL initiation and beyond.
  • Treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL.

Alkermes Announces Former Professional Baseball Player, CC Sabathia, as Spokesperson for Alcohol Dependence Awareness Campaign

Retrieved on: 
Tuesday, June 22, 2021

DUBLIN, June 22, 2021 /PRNewswire/ -- Alkermes, Inc. , a subsidiary of Alkermes plc(Nasdaq: ALKS), today announced former professional baseball player and World Series champion, CC Sabathia, as a spokesperson for the company's My Relationship with Alcohol campaign, which is designed to help raise awareness about the disease of alcohol dependence and encourage people who are rethinking their relationship with alcohol to reach out to their healthcare provider.

Key Points: 
  • DUBLIN, June 22, 2021 /PRNewswire/ -- Alkermes, Inc. , a subsidiary of Alkermes plc(Nasdaq: ALKS), today announced former professional baseball player and World Series champion, CC Sabathia, as a spokesperson for the company's My Relationship with Alcohol campaign, which is designed to help raise awareness about the disease of alcohol dependence and encourage people who are rethinking their relationship with alcohol to reach out to their healthcare provider.
  • CC Sabathia has been outspoken about his own alcohol dependence recovery journey in an effort to inspire others who may be struggling with the disease to seek help.
  • "I battled with my drinking for years before making the decision to seek professional help, so I'm looking forward to being part of this campaign to help people rethink their relationship with alcohol," said CC Sabathia.
  • Alcohol dependenceis a chronic disease in which a person craves drinks that contain alcohol and is unable to control their drinking.

Alkermes Announces Former Professional Baseball Player, CC Sabathia, as Spokesperson for Alcohol Dependence Awareness Campaign

Retrieved on: 
Tuesday, June 22, 2021

DUBLIN, June 22, 2021 /PRNewswire/ -- Alkermes, Inc. , a subsidiary of Alkermes plc(Nasdaq: ALKS), today announced former professional baseball player and World Series champion, CC Sabathia, as a spokesperson for the company's My Relationship with Alcohol campaign, which is designed to help raise awareness about the disease of alcohol dependence and encourage people who are rethinking their relationship with alcohol to reach out to their healthcare provider.

Key Points: 
  • DUBLIN, June 22, 2021 /PRNewswire/ -- Alkermes, Inc. , a subsidiary of Alkermes plc(Nasdaq: ALKS), today announced former professional baseball player and World Series champion, CC Sabathia, as a spokesperson for the company's My Relationship with Alcohol campaign, which is designed to help raise awareness about the disease of alcohol dependence and encourage people who are rethinking their relationship with alcohol to reach out to their healthcare provider.
  • CC Sabathia has been outspoken about his own alcohol dependence recovery journey in an effort to inspire others who may be struggling with the disease to seek help.
  • "I battled with my drinking for years before making the decision to seek professional help, so I'm looking forward to being part of this campaign to help people rethink their relationship with alcohol," said CC Sabathia.
  • Alcohol dependenceis a chronic disease in which a person craves drinks that contain alcohol and is unable to control their drinking.

Global Alcohol Dependence Epidemiology and Patient Flow Report 2020-2035: Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 5, 2021

b'The "Global Alcohol Dependence Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Alcohol Dependence Epidemiology and Patient Flow Analysis - 2021, provides Alcohol Dependence epidemiology, demographics, and patient flow.

Key Points: 
  • b'The "Global Alcohol Dependence Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com\'s offering.\nGlobal Alcohol Dependence Epidemiology and Patient Flow Analysis - 2021, provides Alcohol Dependence epidemiology, demographics, and patient flow.
  • The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.\nThe research provides population data to characterize Alcohol Dependence patients, history of the disease at the population level (Alcohol Dependence prevalence, Alcohol Dependence incidence) and at the clinical level (from diagnosis to treated patients).
  • It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.\nDemographics: Alcohol Dependence patients by age group, gender\nThe data from this research will help executives:\nEstablish basis for Alcohol Dependence market sizing, assessing market potential, and developing drug forecast models\nIdentify Alcohol Dependence patients segments through age groups, gender, and disease sub-types\nEvaluate Alcohol Dependence market opportunities, identify target patient population\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210505005460/en/\n'